Estimation of changes induced by drugs in cerebral energy-coupling processes in situ in the dog.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000758:Anesthesia; D000818:Animals; D001534:Bemegride / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D001966:Bromine / Q000494:pharmacology; D002339:Carotid Arteries / Q000502:physiology; D003042:Cocaine / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology*; D004285:Dogs; D004569:Electroencephalography; D004735:Energy Transfer / Q000187:drug effects*; D004873:Ergolines / Q000494:pharmacology*; D005263:Femoral Artery / Q000502:physiology; D007003:Hypoglycemia / Q000378:metabolism; D007022:Hypotension / Q000378:metabolism; D000860:Hypoxia / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D008026:Ligation; D008297:Male; D008314:Malonates / Q000494:pharmacology; D009243:NAD / Q000378:metabolism; D009539:Nicotinic Acids / Q000494:pharmacology; D011773:Pyruvates / Q000378:metabolism; D013997:Time Factors; D014520:Urethane
D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D007773:Lactates; D008314:Malonates; D009539:Nicotinic Acids; D011773:Pyruvates; D009243:NAD; D014520:Urethane; D001534:Bemegride; D004176:Dipyridamole; D000255:Adenosine Triphosphate; D003042:Cocaine; D001966:Bromine